A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

Basepair, a leader in cloud-native bioinformatics analysis, and Sciencewerke Pty Ltd, an Australian specialist in research ...

Biotech company 10x Genomics (NASDAQ:TXG) reported in Q4 CY2025, but sales were flat year on year at $166 million. The ...

Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.

Moby Strategic Performance Drivers and Market Dynamics. Management attributed Q4 performance to a modest year-end budget ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 10.5% in the morning session after the company reported better-than-expected fourth-quarter results, highlighted by a smaller loss than ...

Modern genomic tools can substantially accelerate restoration of the American chestnut while preserving its ecological ...

Genomics announced new multi year collaborations in cancer research with PharosAI, the Cancer Research Institute, and Dana Farber Cancer Institute. The partners plan to use 10x Genomics spatial ...

Current Genomics is now accepting submissions. This journal publishes high-impact research across genome science, including ...

10x Genomics (TXG) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.4 per share a year ago. These figures are ...

Shares of 10x Genomics rose after the company narrowed its loss in the fourth quarter, beating Wall Street estimates. Shares were up 11% at $19.41 late Friday morning. The stock has gained 60% over ...